![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Significantly Higher Clinical and Economic Burden Following Diagnosis of Hepatitis Delta Virus Infection Among Commercially Insured Adults With Chronic Hepatitis B in the United States
|
|
|
EASL 2023 June 23 Vienna
Robert J Wong1,2, Robert G Gish3, Chong Kim4, Gary Leung5, Ira M Jacobson6, Joseph K Lim7, Ankita Kaushik4
1Stanford University School of Medicine, Stanford, CA, USA; 2VA Palo Alto Healthcare System, Palo Alto, CA, USA; 3Hepatitis B Foundation, Doylestown, PA, USA; 4HEOR - Global Value & Access, Gilead Sciences, Inc., Foster City, CA, USA; 5RWE - Epidemiology, Gilead Sciences, Inc., Foster City, CA, USA; 6NYU Grossman School of Medicine, New York, NY, USA; 7Yale University School of Medicine, New Haven, CT, USA
![0629231](../images/062923/062823-3/0629231.gif)
![0629232](../images/062923/062823-3/0629232.gif)
![0629233](../images/062923/062823-3/0629233.gif)
![0629234](../images/062923/062823-3/0629234.gif)
![0629235](../images/062923/062823-3/0629235.gif)
![0629236](../images/062923/062823-3/0629236.gif)
![0629237](../images/062923/062823-3/0629237.gif)
![0629238](../images/062923/062823-3/0629238.gif)
![0629239](../images/062923/062823-3/0629239.gif)
![06292310](../images/062923/062823-3/06292310.gif)
![06292311](../images/062923/062823-3/06292311.gif)
![06292312](../images/062923/062823-3/06292312.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|